CONNECTIVE TISSUE DISEASE-ASSOCIATED INTERSTITIAL LUNG DISEASE
Clinical trials for CONNECTIVE TISSUE DISEASE-ASSOCIATED INTERSTITIAL LUNG DISEASE explained in plain language.
Never miss a new study
Get alerted when new CONNECTIVE TISSUE DISEASE-ASSOCIATED INTERSTITIAL LUNG DISEASE trials appear
Sign up with your email to follow new studies for CONNECTIVE TISSUE DISEASE-ASSOCIATED INTERSTITIAL LUNG DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with untreatable autoimmune diseases
Disease control Recruiting nowThis early-stage study is testing a new cell therapy called CAR-NK for children with severe rheumatic diseases that haven't responded to standard treatments. Doctors will give a single infusion of these specially modified immune cells to see if it's safe and can help put the dise…
Matched conditions: CONNECTIVE TISSUE DISEASE-ASSOCIATED INTERSTITIAL LUNG DISEASE
Phase: EARLY_PHASE1 • Sponsor: The Children's Hospital of Zhejiang University School of Medicine • Aim: Disease control
Last updated Apr 02, 2026 02:11 UTC
-
New hope for controlling scarred lungs in autoimmune disease patients
Disease control Recruiting nowThis study is testing whether adding a drug called tetrandrine to standard treatment can better control lung scarring in adults with connective tissue disease-related interstitial lung disease. About 100 participants will take either tetrandrine or a placebo pill for 24 weeks whi…
Matched conditions: CONNECTIVE TISSUE DISEASE-ASSOCIATED INTERSTITIAL LUNG DISEASE
Phase: PHASE4 • Sponsor: Peking University Third Hospital • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC